0000899243-23-005242.txt : 20230216
0000899243-23-005242.hdr.sgml : 20230216
20230216160517
ACCESSION NUMBER: 0000899243-23-005242
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230216
DATE AS OF CHANGE: 20230216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamdy Ahmed MD
CENTRAL INDEX KEY: 0001458506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39244
FILM NUMBER: 23638529
MAIL ADDRESS:
STREET 1: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vincerx Pharma, Inc.
CENTRAL INDEX KEY: 0001796129
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833197402
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-800-6676
MAIL ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Vincera Pharma, Inc.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: LifeSci Acquisition Corp.
DATE OF NAME CHANGE: 20191206
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-15
0
0001796129
Vincerx Pharma, Inc.
VINC
0001458506
Hamdy Ahmed MD
260 SHERIDAN AVENUE, SUITE 400
PALO ALTO
CA
94306
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
1.17
2023-02-15
4
A
0
90000
0.00
A
2033-02-14
Common Stock
90000
90000
D
Option vests in twenty-four equal monthly installments starting from February 15, 2023.
Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.
By: /s/ Ahmed M. Hamdy
2023-02-16